Prelude Capital Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
+109,427
| New | +$249K | 0.02% | 692 |
|
|
2024
Q3 | – | Sell |
-266,692
| Closed | -$928K | – | 1171 |
|
|
2024
Q2 | $928K | Buy |
+266,692
| New | +$928K | 0.06% | 295 |
|
|
2020
Q1 | – | Sell |
-460
| Closed | -$6K | – | 962 |
|
|
2019
Q4 | $6K | Sell |
460
-80
| -15% | -$1.04K | ﹤0.01% | 1278 |
|
|
2019
Q3 | $7K | Sell |
540
-50
| -8% | -$648 | ﹤0.01% | 1037 |
|
|
2019
Q2 | $9K | Buy |
590
+203
| +52% | +$3.1K | ﹤0.01% | 1031 |
|
|
2019
Q1 | $12K | Sell |
387
-7
| -2% | -$217 | ﹤0.01% | 1018 |
|
|
2018
Q4 | $13K | Sell |
394
-30,418
| -99% | -$1M | ﹤0.01% | 980 |
|
|
2018
Q3 | $945K | Buy |
30,812
+18,646
| +153% | +$572K | 0.05% | 243 |
|
|
2018
Q2 | $326K | Buy |
+12,166
| New | +$326K | 0.02% | 510 |
|